文献速递主动脉疾病

影像融合引导下顺行激光开窗与定制支架治疗复杂主动脉瘤的初步结果

Initial Results of Antegrade Laser Fenestrations Using Image Fusion Guidance and Company Manufactured Stent Grafts in Complex Aortic Aneurysm Repair.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2021-05-14

该单中心回顾性研究比较了LEVAR(医生改良支架联合顺行激光开窗和影像融合引导)与Zenith定制支架(CM)治疗复杂腹主动脉瘤、胸腹主动脉瘤和I型内漏的初步结局。

要点

  • 两组1年总生存率均为91%,目标血管通畅率均为95%。
  • LEVAR组1年免于再干预率较低(58% vs 87%),需密切随访。

核心结论

  • 对于不适合开放手术的高危患者,LEVAR可提供满意的1年总生存率和目标血管通畅率,但术中不良事件、死亡和再干预率较高,需要密切和广泛的随访。

主要发现

  • LEVAR组中位随访22个月(7-38),CM组28个月(11-78)。
  • 两组1年总生存率估计均为91%。
  • LEVAR组1年免于再干预率为58%,CM组为87%;两组1年目标血管通畅率均为95%。

临床怎么用

  • LEVAR可作为不适合开放手术的高危复杂主动脉瘤患者的治疗选择,但需警惕较高的术中不良事件和再干预风险,并加强术后随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim was to describe initial outcomes of physician modified stent grafts using antegrade laser fenestrations and image fusion guidance (LEVAR) and company manufactured custom made (CM) stent grafts for the treatment of complex abdominal aortic aneurysms (CAAAs), thoraco-abdominal aortic aneurysms (TAAAs) and type I endoleaks (T1ELs). METHODS: This was a retrospective single centre study. All LEVAR and Zenith (Cook) CM stent graft procedures between 1 January 2012 and 31 December 2018 were reviewed. Endpoints included intra-operative adverse events (IOAEs), in hospital mortality, re-interventions, target vessel patency, and 12 month outcomes (overall survival, freedom from re-intervention, target vessel patency). Outcomes at 12 months were estimated using the Kaplan-Meier method. RESULTS: A hundred patients were identified and included in the study. All patients were deemed unfit for open repair. The cohort included 22 LEVAR and 78 CM stent grafts. LEVAR cases included painful aneurysms (n = 5), > 65 mm aneurysms (n = 10), anatomical constrains and/or presence of previous renal stents (n = 7) or cases declined by the manufacturer planning centre (n = 2). IOAEs were recorded in 41% of cases (n = 9) in the LEVAR group vs. 10% (n = 8, p = .002) in the CM group. The in hospital mortality rate in the LEVAR group was 9% (n = 2) vs. 4% (n = 3, p = .30) in the CM group. The median follow up duration was 22 months (7 - 38) in the LEVAR group and 28 months (11 - 78) in the CM group. The estimate of overall survival at one year was 91% in both groups. The freedom from re-intervention rate at one year was 58% in the LEVAR group vs. 87% in the CM group. The target vessel patency rates at one year were 95% in both groups. CONCLUSION: In high risk patients deemed unfit for open repair, LEVAR may provide satisfactory 12 month overall survival and target vessel patency rates, though reported IOAE, mortality, and re-interventions rates were high thus requiring close and extensive follow up.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Sénémaud J, Fadel G, Touma J, et al. Initial Results of Antegrade Laser Fenestrations Using Image Fusion Guidance and Company Manufactured Stent Grafts in Complex Aortic Aneurysm Repair. Eur J Vasc Endovasc Surg. 2021. PMID: 33994306. doi:10.1016/j.ejvs.2021.03.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。